Skip to content

Clinical trials

Completed Diabetes Mellitus, Type 1 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Status: Completed Country / region: Japan Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20024
20033
20042
20071
20091
20104
20113
20126
20132
20141
20154
20165
20171
20182
20191
20201
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S23
Eli Lilly and Company7
Sanofi7
AstraZeneca3
Astellas Pharma Inc2
Boehringer Ingelheim1
Regeneron Pharmaceuticals1
Sanwa Kagaku Kenkyusho Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 145
Diabetes Mellitus22
Diabetes Mellitus, Type 29
Insulin Resistance1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.